TiumBio Co., Ltd. (KOSDAQ:321550)
South Korea
· Delayed Price · Currency is KRW 6,670.00
-180.00 (-2.63%)
At close: Dec 5, 2025
TiumBio Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Revenue | 9,323 | 6,792 | 4,899 | 9,118 | 56.8 | 1,049 | Upgrade
|
| Revenue Growth (YoY) | 21.54% | 38.65% | -46.27% | 15952.75% | -94.58% | -5.75% | Upgrade
|
| Gross Profit | 7,906 | 6,792 | 4,899 | 9,118 | 56.8 | 1,049 | Upgrade
|
| Selling, General & Admin | 12,367 | 12,212 | 11,610 | 9,999 | 5,008 | 3,504 | Upgrade
|
| Research & Development | 10,553 | 9,481 | 17,867 | 21,287 | 25,801 | 9,830 | Upgrade
|
| Amortization of Goodwill & Intangibles | 140.11 | 344.51 | 529.2 | 526.84 | 469.03 | 455.99 | Upgrade
|
| Operating Expenses | 26,475 | 25,491 | 32,731 | 34,758 | 32,753 | 14,352 | Upgrade
|
| Operating Income | -18,569 | -18,699 | -27,832 | -25,640 | -32,696 | -13,303 | Upgrade
|
| Interest Expense | -4,947 | -4,044 | -2,471 | -808.36 | -518.46 | -40.85 | Upgrade
|
| Interest & Investment Income | 514.35 | 479.94 | 1,225 | 1,305 | 919.34 | 1,215 | Upgrade
|
| Earnings From Equity Investments | 12,390 | 11,171 | -1,257 | -1,303 | -385.86 | - | Upgrade
|
| Currency Exchange Gain (Loss) | 54.48 | 141.51 | 127.42 | 65.61 | -11.63 | -99.27 | Upgrade
|
| Other Non Operating Income (Expenses) | -1,629 | -8,762 | -2,337 | -3,991 | 612.57 | 17.54 | Upgrade
|
| EBT Excluding Unusual Items | -12,187 | -19,712 | -32,544 | -30,372 | -32,080 | -12,211 | Upgrade
|
| Gain (Loss) on Sale of Investments | -1,383 | -5,873 | 1,728 | -1,037 | -172.6 | 93.07 | Upgrade
|
| Gain (Loss) on Sale of Assets | -19.12 | -10.1 | -13.27 | 6.28 | -0 | -0.45 | Upgrade
|
| Other Unusual Items | 57.89 | 2,049 | 11,792 | - | - | - | Upgrade
|
| Pretax Income | -13,531 | -23,546 | -19,038 | -31,402 | -32,253 | -12,119 | Upgrade
|
| Earnings From Continuing Operations | -13,531 | -23,546 | -19,038 | -31,402 | -32,253 | -12,119 | Upgrade
|
| Minority Interest in Earnings | 1,801 | 2,903 | 1,127 | 1,550 | 615.61 | - | Upgrade
|
| Net Income | -11,730 | -20,644 | -17,911 | -29,853 | -31,637 | -12,119 | Upgrade
|
| Net Income to Common | -11,730 | -20,644 | -17,911 | -29,853 | -31,637 | -12,119 | Upgrade
|
| Shares Outstanding (Basic) | 27 | 26 | 24 | 24 | 24 | 23 | Upgrade
|
| Shares Outstanding (Diluted) | 27 | 26 | 24 | 24 | 24 | 23 | Upgrade
|
| Shares Change (YoY) | 4.33% | 5.91% | 1.79% | 0.63% | 1.39% | 17.20% | Upgrade
|
| EPS (Basic) | -441.55 | -799.09 | -734.27 | -1245.75 | -1328.50 | -515.97 | Upgrade
|
| EPS (Diluted) | -441.55 | -799.09 | -734.27 | -1246.00 | -1329.00 | -516.00 | Upgrade
|
| Free Cash Flow | -14,220 | -16,668 | -38,952 | -27,198 | -36,647 | -10,246 | Upgrade
|
| Free Cash Flow Per Share | -535.28 | -645.20 | -1596.88 | -1134.99 | -1538.88 | -436.25 | Upgrade
|
| Gross Margin | 84.80% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -199.18% | -275.30% | -568.14% | -281.22% | -57566.15% | -1268.26% | Upgrade
|
| Profit Margin | -125.81% | -303.93% | -365.62% | -327.42% | -55701.69% | -1155.33% | Upgrade
|
| Free Cash Flow Margin | -152.52% | -245.40% | -795.14% | -298.31% | -64522.48% | -976.81% | Upgrade
|
| EBITDA | -14,908 | -14,901 | -24,578 | -22,169 | -30,753 | -12,285 | Upgrade
|
| EBITDA Margin | -159.90% | -219.38% | - | -243.14% | - | - | Upgrade
|
| D&A For EBITDA | 3,662 | 3,799 | 3,254 | 3,472 | 1,944 | 1,018 | Upgrade
|
| EBIT | -18,569 | -18,699 | -27,832 | -25,640 | -32,696 | -13,303 | Upgrade
|
| EBIT Margin | -199.18% | -275.30% | - | -281.22% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.